Vidari Kanda for Lactation Support

Insufficient evidence 3 studies

Research suggests that Vidari Kanda, derived from plants including Pueraria tuberosa and Ipomoea mauritiana, has traditional and preliminary scientific support as a galactagogue. Studies indicate that Pueraria tuberosa extract and its constituent puerarin increased milk yield and serum prolactin levels in a rat model, while two additional sources document Ipomoea mauritiana's traditional Ayurvedic use for improving breast milk production. The available evidence consists of one animal study and two descriptive or traditional-use references rather than controlled human clinical trials, which represents a significant limitation in drawing firm conclusions about efficacy in humans. Overall, the research direction is supportive of lactation-related claims, but the absence of robust human trials means the evidence base remains preliminary and exploratory.

Related studies

Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.

Title Type Year Direction Match
In vivo analysis of puerarin from Pueraria tuberosa as a promising galactagogue. Other 2024 Supports 85
Development of Randomly Amplified Polymorphic DNA Based SCAR Marker for Ident... Other 2011 Supports 72
Qualitative dataset on UPLC-QTOF/MS tentative identification of phytochemical... Other 2021 Supports 65

← Back to Vidari Kanda

Medical Disclaimer: Noyemi provides information from published research for educational purposes only. This content is not medical advice and does not replace consultation with a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any supplement regimen, especially if you take medications or have existing health conditions.